KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Steris (STE) Revenue (2018 - 2025)

Steris has reported Revenue over the past 8 years, most recently at $1.5 billion for Q4 2025.

  • For Q4 2025, Revenue rose 9.16% year-over-year to $1.5 billion; the TTM value through Dec 2025 reached $5.8 billion, up 7.96%, while the annual FY2025 figure was $5.5 billion, 6.24% up from the prior year.
  • Revenue for Q4 2025 was $1.5 billion at Steris, up from $1.5 billion in the prior quarter.
  • Over five years, Revenue peaked at $1.5 billion in Q4 2025 and troughed at $873.5 million in Q1 2021.
  • A 5-year average of $1.2 billion and a median of $1.3 billion in 2023 define the central range for Revenue.
  • Biggest five-year swings in Revenue: skyrocketed 58.3% in 2021 and later fell 8.86% in 2022.
  • Year by year, Revenue stood at $1.2 billion in 2021, then dropped by 7.99% to $1.1 billion in 2022, then rose by 16.66% to $1.3 billion in 2023, then increased by 5.62% to $1.4 billion in 2024, then rose by 9.16% to $1.5 billion in 2025.
  • Business Quant data shows Revenue for STE at $1.5 billion in Q4 2025, $1.5 billion in Q3 2025, and $1.4 billion in Q2 2025.